Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis in Children With Pyelonephritis
NCT00752375Phase 3Withdrawn
- Sponsor
- University of Alberta
- Start
- Feb 2009
- Primary completion
- Dec 2014
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of trimethoprim + sulfamethoxazole, amoxicillin and nitrofurantoin in urinary tract infection (UTI) (2 arms), sponsored by University of Alberta. Primary endpoint: Incidence of urinary tract infections at 1 year. Planned start Feb 2009; status: withdrawn.
02
Drugs
trimethoprim + sulfamethoxazoleamoxicillinnitrofurantoin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT00752375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752375.